Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting250%
completed125%
unknown125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

NCT06501560
recruiting

Study of the Role of Genetic Modifiers in Hemoglobinopathies

NCT05799118
unknown

GWAS in NMDAR Encephalitis

NCT05225883
completednot_applicable

GWAS in a Small Group of Metabolically Healthy Obese White Adults

NCT02105909

Clinical Trials (4)

Showing 4 of 4 trials
NCT06501560Not Applicable

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

Recruiting
NCT05799118

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Recruiting
NCT05225883

GWAS in NMDAR Encephalitis

Unknown
NCT02105909Not Applicable

GWAS in a Small Group of Metabolically Healthy Obese White Adults

Completed

All 4 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
4